Tergaonkar V - Search Results

1

NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition.

Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. Mirzaei S, et al. Among authors: tergaonkar v. J Cell Physiol. 2022 Jul;237(7):2770-2795. doi: 10.1002/jcp.30759. Epub 2022 May 13. J Cell Physiol. 2022. PMID: 35561232 Review.

2

Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function?

Ang HL, Tergaonkar V. Ang HL, et al. Among authors: tergaonkar v. Bioessays. 2007 Oct;29(10):1039-47. doi: 10.1002/bies.20647. Bioessays. 2007. PMID: 17876798

3

R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.

Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP. Dey A, et al. Among authors: tergaonkar v. Cell Death Differ. 2008 Feb;15(2):263-73. doi: 10.1038/sj.cdd.4402257. Epub 2007 Nov 2. Cell Death Differ. 2008. PMID: 17975552

4

Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy.

Dey A, Wong E, Kua N, Teo HL, Tergaonkar V, Lane D. Dey A, et al. Among authors: tergaonkar v. Cell Cycle. 2008 Dec;7(23):3759-67. doi: 10.4161/cc.7.23.7213. Epub 2008 Dec 10. Cell Cycle. 2008. PMID: 19029824

5

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

Wong ET, Tergaonkar V. Wong ET, et al. Among authors: tergaonkar v. Clin Sci (Lond). 2009 Mar;116(6):451-65. doi: 10.1042/CS20080502. Clin Sci (Lond). 2009. PMID: 19200055 Review.

6

WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Chew J, Biswas S, Shreeram S, Humaidi M, Wong ET, Dhillion MK, Teo H, Hazra A, Fang CC, López-Collazo E, Bulavin DV, Tergaonkar V. Chew J, et al. Among authors: tergaonkar v. Nat Cell Biol. 2009 May;11(5):659-66. doi: 10.1038/ncb1873. Epub 2009 Apr 19. Nat Cell Biol. 2009. PMID: 19377466

7

Potential pharmacological control of the NF-κB pathway.

Sethi G, Tergaonkar V. Sethi G, et al. Among authors: tergaonkar v. Trends Pharmacol Sci. 2009 Jun;30(6):313-21. doi: 10.1016/j.tips.2009.03.004. Epub 2009 May 14. Trends Pharmacol Sci. 2009. PMID: 19446347 Review.

8

Multifaceted link between cancer and inflammation.

Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Sethi G, et al. Among authors: tergaonkar v. Biosci Rep. 2012 Feb;32(1):1-15. doi: 10.1042/BSR20100136. Biosci Rep. 2012. PMID: 21981137 Review.

9

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.

Rajendran P, Li F, Shanmugam MK, Kannaiyan R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, Luk JM, Sethi G. Rajendran P, et al. Among authors: tergaonkar v. Cancer Prev Res (Phila). 2012 Apr;5(4):631-43. doi: 10.1158/1940-6207.CAPR-11-0420. Epub 2012 Feb 27. Cancer Prev Res (Phila). 2012. PMID: 22369852

10

Telomerase directly regulates NF-κB-dependent transcription.

Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, Zhou J, Chng WJ, Li S, Liu E, Tergaonkar V. Ghosh A, et al. Among authors: tergaonkar v. Nat Cell Biol. 2012 Dec;14(12):1270-81. doi: 10.1038/ncb2621. Epub 2012 Nov 18. Nat Cell Biol. 2012. PMID: 23159929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page